1–10 of 38 results for AMD-Non-neovascular
Impact of Baseline Imbalances on the Efficacy of Pegcetacoplan for the Treatment of GA: A Post Hoc Analysis of OAKS, DERBY, and FILLY
Sunir J. Garg, MD, FACS, FASRS
Updates from the Field
2022
Association of Ocular Antihypertensive Medications and the Development and Progression of Macular Degeneration in a US Insurance Claims Database
Thomas J Wubben, MD, PhD
On Demand Cases, Courses, and Papers
2020
Assessment of Progression of Geographic Atrophy in the FILLY Study
David R Lally, MD
Pentosan Polysulfate Maculopathy: Disease Course After Drug Cessation
Rachel Shah, MD
Annual Meeting Talks
Nonneovascular Age Related Macular Degeneration and Fluid
David Sarraf, MD
Cognitive Testing in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
Subhransu K. Ray, MD, PhD
Impact of Baseline OCT Characteristics on Response to Risuteganib for the Treatment of Intermediate Age-Related Macular Degeneration
Justis P. Ehlers, MD, FASRS
Pentosan Polysulfate Maculopathy Versus Age-Related Macular Degeneration: Comparative Assessment With Multimodal Imaging
Joseph S Christiansen, MD
Phase 1 Safety Study of Intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a Novel Serine Protease Inhibitor, in Patients With GA
William Z. Bridges, MD
Ten-Year Follow-up Data From the AREDS2 Study
Emily Y. Chew, MD
2021